Literature DB >> 15552520

Benefit and risk of methotrexate treatment in rheumatoid arthritis.

R Rau1, G Herborn.   

Abstract

This is a literature review on the efficacy and toxicity of low dose weekly methotrexate treatment in rheumatoid arthritis. Personal recommendations on dosing and monitoring (of) the drug are given.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15552520

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


  16 in total

Review 1.  Three decades of low-dose methotrexate in rheumatoid arthritis: can we predict toxicity?

Authors:  Vasco C Romão; Aurea Lima; Miguel Bernardes; Helena Canhão; João Eurico Fonseca
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

2.  [Methotrexate: advantages of subcutaneous administration].

Authors:  K Krüger
Journal:  Z Rheumatol       Date:  2008-07       Impact factor: 1.372

Review 3.  Management issues with elderly-onset rheumatoid arthritis: an update.

Authors:  Ignazio Olivieri; Carlo Palazzi; Giovanni Peruz; Angela Padula
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

4.  Stealth Nanogels of Histinylated Poly Ethyleneimine for Sustained Delivery of Methotrexate in Collagen-Induced Arthritis Model.

Authors:  SamiraSadat Abolmaali; AliMohammad Tamaddon; Eskandar Kamali-Sarvestani; MohammadJavad Ashraf; Rasoul Dinarvand
Journal:  Pharm Res       Date:  2015-05-12       Impact factor: 4.200

5.  Tc-99 m diethylenetriamine-pentaacetic acid (DTPA): is it reliable for assessment of methotrexate-induced cumulative effect on renal filtration in rheumatoid arthritis patients?

Authors:  Amr Amin; Dina Effat; Nabila Goher; Basma Ramadan
Journal:  Rheumatol Int       Date:  2012-12-23       Impact factor: 2.631

6.  Synergistic Effects of BTK Inhibitor HM71224 and Methotrexate in a Collagen-induced Arthritis Rat Model.

Authors:  Kyung Jin Choi; Yu-Yon Kim; Sun Young Jang; Young Gil Ahn; Kwee Hyun Suh; Young Hoon Kim; Hyung Sik Kim
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

7.  Comparison of two different folic acid doses with methotrexate--a randomized controlled trial (FOLVARI Study).

Authors:  Varun Dhir; Amit Sandhu; Jasbinder Kaur; Benzeeta Pinto; Phani Kumar; Prabhdeep Kaur; Nidhi Gupta; Ankita Sood; Aman Sharma; Shefali Sharma
Journal:  Arthritis Res Ther       Date:  2015-06-11       Impact factor: 5.156

8.  Fructose 1,6-bisphosphate, a high-energy intermediate of glycolysis, attenuates experimental arthritis by activating anti-inflammatory adenosinergic pathway.

Authors:  Flávio P Veras; Raphael S Peres; André L L Saraiva; Larissa G Pinto; Paulo Louzada-Junior; Thiago M Cunha; Jonas A R Paschoal; Fernando Q Cunha; José C Alves-Filho
Journal:  Sci Rep       Date:  2015-10-19       Impact factor: 4.379

9.  Methotrexate-induced pneumonitis in Crohn's disease. Case report and review of the literature.

Authors:  Nadia D'Andrea; Luca Triolo; Giovanna Margagnoni; Annalisa Aratari; Claudio M Sanguinetti
Journal:  Multidiscip Respir Med       Date:  2010-10-31

10.  DMARD non-use in low-income, elderly rheumatoid arthritis patients: results of 86 structured interviews.

Authors:  Erika M Brown; Katie L Garneau; Hsun Tsao; Daniel H Solomon
Journal:  Arthritis Res Ther       Date:  2014-01-29       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.